Stock listing
GNPX Stock Price, News, Filings & Events — Genprex, Inc.
Selected listing: GNPX · NASDAQ · USD · US
This page tracks Genprex, Inc.'s GNPX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GNPX:NASDAQ. GNPX:NASDAQ is the stock-level entry point for investors researching Genprex, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genprex, Inc. (GNPX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
- Ticker
- GNPX:NASDAQ
- Asset type
- Stock
- Market cap
- $3.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Genprex, Inc. GNPX:NASDAQ stock context
This page tracks Genprex, Inc.'s GNPX:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following GNPX:NASDAQ. GNPX:NASDAQ is the stock-level entry point for investors researching Genprex, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Genprex, Inc. (GNPX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Genprex, Inc.
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
September 1, 2026
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabete...
August 18, 2026
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
August 3, 2026
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® G...
June 22, 2026
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa® Gene Therapy Published at the 2026 ASCO Annual Meeting
May 26, 2026
Research Genprex, Inc.
Genprex, Inc. investor report
Review AI stock analysis and investor report context for GNPX:NASDAQ.
Genprex, Inc. company profile
View the public company page for Genprex, Inc. on 6ix.
Genprex, Inc. news
Read company news and market updates connected to Genprex, Inc..
Genprex, Inc. investor events
Find investor webinars, events, and replay context for Genprex, Inc..
Alternate listings
GNPX:BOATS
US · USD
Alternate listing for Genprex, Inc.; the primary context on this page is GNPX:NASDAQ.
2DE:FWB
DE · EUR
Alternate listing for Genprex, Inc.; the primary context on this page is GNPX:NASDAQ.
0A8I:LSE
GB · USD
Alternate listing for Genprex, Inc.; the primary context on this page is GNPX:NASDAQ.
2DE:GETTEX
DE · EUR
Alternate listing for Genprex, Inc.; the primary context on this page is GNPX:NASDAQ.
2DE:MUN
DE · EUR
Alternate listing for Genprex, Inc.; the primary context on this page is GNPX:NASDAQ.